Maoqiang Li

853 citations
36 papers · 677 indexed · h-index 16
Topics
Orthopaedic implants and arthroplasty (5 papers)Inflammasome and immune disorders (5 papers)MicroRNA in disease regulation (4 papers)
Partner nations
ChinaUnited States

In The Last Decade

Maoqiang Li

32 papers receiving 672 citations

Peers

Maoqiang Li
Comparison fields: 5 of 88
  • Molecular Biology 396
  • Pathology and Forensic Medicine 174
  • Cancer Research 114
  • Surgery 87
  • Immunology 77
Replace Wu Jiang with:
Wu Jiang China
Fei Lan China
Yongxiang Yang China
Manhui Zhu China
Xinghui Song China
Libin Ni China
Hua Piao China
Yanwu Xu China
Weibin Lin China
Minfei Wu China
Maoqiang Li relative to Wu Jiang China Wu Jiang's profile →
Citations per field
00.5×
Wu Jiang · 1×
Citations per year

Countries citing papers authored by Maoqiang Li

Since Specialization
Citations

This map shows the geographic impact of Maoqiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maoqiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maoqiang Li more than expected).

Fields of papers citing papers by Maoqiang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maoqiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maoqiang Li. The network helps show where Maoqiang Li may publish in the future.

Co-authorship network of co-authors of Maoqiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Maoqiang Li. A scholar is included among the top collaborators of Maoqiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maoqiang Li. Maoqiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 0
3 0
4 0
5 19
6 15
7 5
8 1
9 3
10 34
11 37
12
CXCR4 enhances invasion and proliferation of bone marrow stem cells via PI3K/AKT/NF-κB signaling pathway.
8
13 0
14 47
15 33
16 55
17 1
18 46
19 1
20 11

About Maoqiang Li

Maoqiang Li is a scholar working on Pathology and Forensic Medicine, Endocrine and Autonomic Systems and Complementary and alternative medicine, having authored 36 papers that have together received 677 indexed citations. Recurring topics across this work include Orthopaedic implants and arthroplasty (5 papers), Inflammasome and immune disorders (5 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (174 citations), Biological Psychiatry (22 citations) and Neurology (67 citations). Maoqiang Li has collaborated with scholars based in China and United States. Frequent co-authors include Wu Jiang, Fan He, Xuepeng Wang, Zhenyu Bian, Liulong Zhu, Shaobo Zhou, Chunming Jiang, Zhanchun Li, Jie Xiao and Kongzu Hu. Their work appears in journals such as International Journal of Molecular Sciences, Spine and Gene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026